Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carbery Group is a global leader in dairy-based nutritional ingredients and flavors, serving the clinical, infant, and sports nutrition markets. The company specializes in the production of advanced whey protein isolates, hydrolysates, and bioactive peptides derived from high-quality Irish dairy. Through its Synergy Flavours division, Carbery offers a comprehensive portfolio of taste solutions integrated with nutritional functionality. As a co-operative owned by four Irish dairy societies, the group emphasizes sustainable manufacturing and extensive R&D in protein science and fermentation. Their flagship products, such as Optipep and Isolac, are widely used in medical nutrition to address conditions like sarcopenia and malnutrition. Headquartered in Ireland, Carbery operates multiple international production facilities across the USA, Brazil, and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carbery Group.